Global Impact of the COVID-19 Pandemic on Cerebral Venous
Thrombosis and Mortality

J 2022

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

NGUYEN, Thanh N, Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER et. al.

Basic information

Original name

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

Authors

NGUYEN, Thanh N (guarantor), Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK (203 Czech Republic, belonging to the institution), Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ (203 Czech Republic), Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO and Raul G NOGUEIRA

Edition

JOURNAL OF STROKE, SEOUL, KOREAN STROKE SOC, 2022, 2287-6391

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30230 Other clinical medicine subjects

Country of publisher

Republic of Korea

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

STROKE

Impact factor

Impact factor: 8.200

RIV identification code

RIV/00216224:14110/22:00127760

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.5853/jos.2022.00752

UT WoS

000812327500008

Keywords (in Czech)

COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; Stroke

Keywords in English

COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; Stroke

Abstract

V originále

Since the first case in December 2019, coronavirus disease 2019 (COVID-19) has been responsible for more than 340 million infections and over 5.5 million deaths.1 Though most of the morbidity and mortality associated with COVID-19 is related to pulmonary complications, the disease has had wide-ranging systemic effects, including a range of neurological manifestations2,3 and disruption of coagulation homeostasis.4-7 This disruption in normal coagulation may trigger abnormal clotting events such as venous thromboembolism and stroke.8-10 Cerebral venous thrombosis (CVT) is a rare cause of stroke caused by the formation of clots in the brain’s venous system. The incidence of CVT has been reported to increase over the last decade, either from changing risk factors or improved detection.11-13 Compared to other forms of stroke, the incidence of CVT is more common in younger patients and women. CVT generally has a favorable prognosis with a good 90-day neurological outcome seen in greater than 80% of patients.

Links

90128, large research infrastructures

Name: CZECRIN III

Citovat

NGUYEN, Thanh N, Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK, Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ, Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO and Raul G NOGUEIRA. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. JOURNAL OF STROKE. SEOUL: KOREAN STROKE SOC, 2022, vol. 24, No 2, p. 256-265. ISSN 2287-6391. Available from: https://dx.doi.org/10.5853/jos.2022.00752.

@article{2244034,
   author = {Nguyen, Thanh N and Qureshi, Muhammad M and Klein, Piers and Yamagami, Hiroshi and Abdalkader, Mohamad and Mikulík, Robert and Sathya, Anvitha and Mansour, Ossama Yassin and Czlonkowska, Anna and Lo, Hannah and Field, Thalia S and Charidimou, Andreas and Banerjee, Soma and Yaghi, Shadi and Siegler, James E and Šedová, Petra and Kwan, Joseph and Aguiar, de Sousa Diana and Demeestere, Jelle and Inoa, Violiza and Omran, Setareh Salehi and Zhang, Liqun and Michel, Patrik and Strambo, Davide and Marto, Joao Pedro and Nogueira, Raul G},
   article_location = {SEOUL},
   article_number = {2},
   doi = {http://dx.doi.org/10.5853/jos.2022.00752},
   keywords = {COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; Stroke},
   language = {eng},
   issn = {2287-6391},
   journal = {JOURNAL OF STROKE},
   title = {Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality},
   url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194544/pdf/jos-2022-00752.pdf},
   volume = {24},
   year = {2022}
}

TY  - JOUR
ID  - 2244034
AU  - Nguyen, Thanh N - Qureshi, Muhammad M - Klein, Piers - Yamagami, Hiroshi - Abdalkader, Mohamad - Mikulík, Robert - Sathya, Anvitha - Mansour, Ossama Yassin - Czlonkowska, Anna - Lo, Hannah - Field, Thalia S - Charidimou, Andreas - Banerjee, Soma - Yaghi, Shadi - Siegler, James E - Šedová, Petra - Kwan, Joseph - Aguiar, de Sousa Diana - Demeestere, Jelle - Inoa, Violiza - Omran, Setareh Salehi - Zhang, Liqun - Michel, Patrik - Strambo, Davide - Marto, Joao Pedro - Nogueira, Raul G
PY  - 2022
TI  - Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality
JF  - JOURNAL OF STROKE
VL  - 24
IS  - 2
SP  - 256-265
EP  - 256-265
PB  - KOREAN STROKE SOC
SN  - 22876391
KW  - COVID-19
KW  - Cerebral venous thrombosis
KW  - Vaccine-induced immune thrombotic thrombocytopenia
KW  - Mortality
KW  - SARS-CoV-2
KW  - Stroke
UR  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194544/pdf/jos-2022-00752.pdf
N2  - Since the first case in December 2019, coronavirus disease 2019 (COVID-19) has been responsible for more than 340 million infections and over 5.5 million deaths.1 Though most of the morbidity and mortality associated with COVID-19 is related to pulmonary complications, the disease has had wide-ranging systemic effects, including a range of neurological manifestations2,3 and disruption of coagulation homeostasis.4-7 This disruption in normal coagulation may trigger abnormal clotting events such as venous thromboembolism and stroke.8-10 Cerebral venous thrombosis (CVT) is a rare cause of stroke caused by the formation of clots in the brain’s venous system. The incidence of CVT has been reported to increase over the last decade, either from changing risk factors or improved detection.11-13 Compared to other forms of stroke, the incidence of CVT is more common in younger patients and women. CVT generally has a favorable prognosis with a good 90-day neurological outcome seen in greater than 80% of patients.
ER  -

NGUYEN, Thanh N, Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK, Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ, Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO and Raul G NOGUEIRA. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. \textit{JOURNAL OF STROKE}. SEOUL: KOREAN STROKE SOC, 2022, vol.~24, No~2, p.~256-265. ISSN~2287-6391. Available from: https://dx.doi.org/10.5853/jos.2022.00752.

Detailed Information on Publication Record